{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:18:18Z","timestamp":1774009098583,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Chinese medicine science and technology plan of Zhejiang Province","award":["2015ZA148"],"award-info":[{"award-number":["2015ZA148"]}]},{"name":"The Chinese medicine science and technology plan of Zhejiang Province","award":["2017ZA109"],"award-info":[{"award-number":["2017ZA109"]}]},{"name":"The Natural Science Foundation of Zhejiang Province","award":["Q18H290004"],"award-info":[{"award-number":["Q18H290004"]}]},{"name":"The Natural Science Foundation of Zhejiang Province","award":["LYY18H300001"],"award-info":[{"award-number":["LYY18H300001"]}]},{"name":"Hangzhou city science and technology project planning guide","award":["2015YD21"],"award-info":[{"award-number":["2015YD21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13346-019-00665-8","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T15:02:32Z","timestamp":1565881352000},"page":"93-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3606-8819","authenticated-orcid":false,"given":"Xin-jun","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-dong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao-yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-jun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"issue":"3","key":"665_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens CL. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309\u201322.","journal-title":"Cancer Cell"},{"key":"665_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.canlet.2017.01.040","volume":"400","author":"YL Chen","year":"2017","unstructured":"Chen YL, Chang CM, Cheng WF. Metronomic chemotherapy and immunotherapy in cancer treatment. Cancer Lett. 2017;400:282\u201392.","journal-title":"Cancer Lett"},{"issue":"8","key":"665_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","volume":"7","author":"E Pasquier","year":"2010","unstructured":"Pasquier E, Koivunen E, Andr\u00e9 N. Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol. 2010;7(8):455\u201365.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"665_CR4","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1073\/pnas.1700340114","volume":"114","author":"F Mpekris","year":"2017","unstructured":"Mpekris F, Baish JW, Stylianopoulos T, Jain RK. Role of vascular normalization in benefit from metronomic chemotherapy. Proc Natl Acad Sci U S A. 2017;114(8):1994\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"665_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2016.12.018","volume":"400","author":"E Biziota","year":"2017","unstructured":"Biziota E, Mavroeidis L, Hatzimichael E, Pappas P. Metronomic chemotherapy: a potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation. Cancer Lett. 2017;400:243\u201351.","journal-title":"Cancer Lett"},{"issue":"2","key":"665_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/vco.12203","volume":"15","author":"S Denies","year":"2017","unstructured":"Denies S, Cicchelero L, de Rooster H, Daminet S, Polis I, Van de Maele I, et al. Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients. Vet Comp Oncol. 2017;15(2):597\u2013605.","journal-title":"Vet Comp Oncol"},{"key":"665_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canlet.2016.09.015","volume":"400","author":"L Cicchelero","year":"2017","unstructured":"Cicchelero L, Denies S, Vanderperren K, Stock E, Van Brantegem L, de Rooster H, et al. Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer: a pilot study. Cancer Lett. 2017;400:205\u201318.","journal-title":"Cancer Lett"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.biomaterials.2016.04.008","volume":"95","author":"X Luan","year":"2016","unstructured":"Luan X, Guan YY, Lovell JF, Zhao M, Lu Q, Liu YR, et al. Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel. Biomaterials. 2016;95:60\u201373.","journal-title":"Biomaterials"},{"key":"665_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-42023-3_11","volume":"936","author":"U Ledzewicz","year":"2016","unstructured":"Ledzewicz U, Schaettler H. Optimizing chemotherapeutic anti-cancer treatment and the tumor microenvironment: an analysis of mathematical models. Adv Exp Med Biol. 2016;936:209\u201323.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"665_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/1440-1681.12515","volume":"43","author":"CC Tsai","year":"2016","unstructured":"Tsai CC, Qiu JT, Tseng CW, Hsu YC. Low-dose metronomic chemotherapy with cisplatin enhanced immunity in a murine model of ectopic cervical cancer. Clin Exp Pharmacol Physiol. 2016;43(2):251\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"665_CR11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.7150\/thno.18816","volume":"7","author":"J Chen","year":"2017","unstructured":"Chen J, Qiao Y, Tang B, Chen G, Liu X, Yang B, et al. Modulation of Salmonella tumor-colonization and intratumoral anti-angiogenesis by triptolide and its mechanism. Theranostics. 2017;7(8):2250\u201360.","journal-title":"Theranostics"},{"issue":"2","key":"665_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2018.01.052","volume":"496","author":"X Li","year":"2018","unstructured":"Li X, Lu Q, Xie W, Wang Y, Wang G. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt\/\u03b2-catenin signaling. Biochem Biophys Res Commun. 2018;496(2):443\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"665_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3727\/096504013X13657689382932","volume":"20","author":"JX Ma","year":"2013","unstructured":"Ma JX, Sun YL, Wang YQ, Wu HY, Jin J, Yu XF. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res. 2013;20(8):359\u201368.","journal-title":"Oncol Res"},{"issue":"1","key":"665_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ijc.24694","volume":"126","author":"MF He","year":"2010","unstructured":"He MF, Huang YH, Wu LW, Ge W, Shaw PC, But PP. Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer. 2010;126(1):266\u201378.","journal-title":"Int J Cancer"},{"issue":"12","key":"665_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41401-018-0084-9","volume":"39","author":"XZ Wang","year":"2018","unstructured":"Wang XZ, Xue RF, Zhang SY, Zheng YT, Zhang LY, Jiang ZZ. Activation of natural killer T cells contributes to triptolide-induced liver injury in mice. Acta Pharmacol Sin. 2018;39(12):1847\u201354.","journal-title":"Acta Pharmacol Sin"},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2016.11.007","volume":"400","author":"AS Abu Lila","year":"2017","unstructured":"Abu Lila AS, Ishida T. Metronomic chemotherapy and nanocarrier platforms. Cancer Lett. 2017;400:232\u201342.","journal-title":"Cancer Lett"},{"issue":"16","key":"665_CR17","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.biomaterials.2013.02.017","volume":"34","author":"DH Yu","year":"2013","unstructured":"Yu DH, Ban FQ, Zhao M, Lu Q, Lovell JF, Bai F, et al. The use of nanoparticulate delivery systems in metronomic chemotherapy. Biomaterials. 2013;34(16):3925\u201337.","journal-title":"Biomaterials"},{"issue":"3","key":"665_CR18","first-page":"722","volume":"60","author":"R Pasqualini","year":"2000","unstructured":"Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 2000;60(3):722\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"665_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2009.05.030","volume":"139","author":"X Wang","year":"2009","unstructured":"Wang X, Wang Y, Chen X, Wang J, Zhang X, Zhang Q. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. J Control Release. 2009;139(1):56\u201362.","journal-title":"J Control Release"},{"issue":"2","key":"665_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jconrel.2009.12.031","volume":"143","author":"AH Negussie","year":"2010","unstructured":"Negussie AH, Miller JL, Reddy G, Drake SK, Wood BJ. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release. 2010;143(2):265\u201373.","journal-title":"J Control Release"},{"issue":"6","key":"665_CR21","first-page":"1239","volume":"34","author":"XJ Cai","year":"2015","unstructured":"Cai XJ, Wang Z, Wang CY, Zhou HJ, Ni JJ, Xu YY, et al. In vitro and in vivo evaluation of cationic liposomes containing zoledronic acid as anticancer agent. Lat Am J Pharm. 2015;34(6):1239\u201345.","journal-title":"Lat Am J Pharm"},{"issue":"8","key":"665_CR22","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.biomaterials.2009.11.047","volume":"31","author":"DH Yu","year":"2010","unstructured":"Yu DH, Lu Q, Xie J, Fang C, Chen HZ. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials. 2010;31(8):2278\u201392.","journal-title":"Biomaterials."},{"issue":"7","key":"665_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/apm.12201","volume":"122","author":"K Norrby","year":"2014","unstructured":"Norrby K. Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth? APMIS. 2014;122(7):565\u201379.","journal-title":"APMIS."},{"issue":"2","key":"665_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CAD.0000000000000173","volume":"26","author":"Z Liu","year":"2015","unstructured":"Liu Z, Zhang F, Koh GY, Dong X, Hollingsworth J, Zhang J, et al. Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles. Anti-Cancer Drugs. 2015;26(2):167\u201379.","journal-title":"Anti-Cancer Drugs"},{"issue":"5665","key":"665_CR25","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1126\/science.1095833","volume":"303","author":"TM Allen","year":"2004","unstructured":"Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303(5665):1818\u201322.","journal-title":"Science."},{"issue":"17","key":"665_CR26","first-page":"3752","volume":"55","author":"F Yuan","year":"1995","unstructured":"Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55(17):3752\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"665_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","volume":"63","author":"S Acharya","year":"2011","unstructured":"Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170\u201383.","journal-title":"Adv Drug Deliv Rev"},{"key":"665_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actbio.2016.04.026","volume":"38","author":"I Banerjee","year":"2016","unstructured":"Banerjee I, De K, Mukherjee D, Dey G, Chattopadhyay S, Mukherjee M. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy. Acta Biomater. 2016;38:69\u201381.","journal-title":"Acta Biomater"},{"issue":"4","key":"665_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.biomaterials.2012.10.029","volume":"34","author":"LM Luo","year":"2013","unstructured":"Luo LM, Huang Y, Zhao BX, Zhao X, Duan Y, Du R. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials. 2013;34(4):1102\u201314.","journal-title":"Biomaterials"},{"issue":"1","key":"665_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jconrel.2012.06.019","volume":"162","author":"K Takara","year":"2012","unstructured":"Takara K, Hatakeyama H, Kibria G, Ohga N, Hida K, Harashima H. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. J Control Release. 2012;162(1):225\u201332.","journal-title":"J Control Release"},{"key":"665_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4615-0169-5_9","volume":"522","author":"P Mancuso","year":"2003","unstructured":"Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, et al. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol. 2003;522:83\u201397.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"665_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10456-012-9321-x","volume":"16","author":"E Pasquier","year":"2013","unstructured":"Pasquier E, Kavallari M, Street J, Sinnappan S, MacKenzie KL, Braguer D, et al. Concentration and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells. Angiogenesis. 2013;16(2):373\u201386.","journal-title":"Angiogenesis."},{"issue":"40","key":"665_CR33","doi-asserted-by":"publisher","first-page":"65429","DOI":"10.18632\/oncotarget.11748","volume":"7","author":"KL Schadler","year":"2016","unstructured":"Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, et al. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget. 2016;7(40):65429\u201340.","journal-title":"Oncotarget."},{"issue":"4","key":"665_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larriv\u00e9e B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409\u201326.","journal-title":"Angiogenesis."},{"key":"665_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","volume":"90","author":"C Xi","year":"2017","unstructured":"Xi C, Peng S, Wu Z, Zhou Q, Zhou J. Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother. 2017;90:531\u201341.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"665_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"P Noel","year":"2019","unstructured":"Noel P, Von Hoff DD, Saluja AK, Velagapudi M, Borazanci E, Han H. Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci. 2019;40(5):327\u201341.","journal-title":"Trends Pharmacol Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-019-00665-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T23:48:38Z","timestamp":1597362518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-019-00665-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s13346-019-00665-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]},"assertion":[{"value":"15 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures related with animal handling and care were carried out under strict compliance with governmental and institutional protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}